For laboratory research use only · Not for human or veterinary use · 18+
Growth hormone research

Buy CJC-1295 no DAC Peptide in Australia

Lyophilised powder, 10mg vial · Available to order, dispatched from Australia
Choose strength: 10 MG
$109.99

Buy CJC-1295 no DAC in Australia from Macropus Peptides in 2mg, 5mg and 10mg research vials, the 10mg size priced and ready to order and the smaller two quoted on request. Also known as Mod GRF 1-29, it is the first 29 amino acids of the releasing hormone, altered at four positions, that slow enzyme breakdown, and without the albumin-binding linker it acts briefly, giving a clean pulse at the pituitary GHRH receptor. Vials contain freeze-dried peptide, sealed and labelled with name, strength, lot number and storage temperature, and the certificate of analysis for each lot is available to buyers. For studies that pair it with a ghrelin receptor agonist, our CJC-1295 and Ipamorelin blend and matching starter kits are stocked beside it. Add bacteriostatic water at checkout and the order ships from local Australian stock to any address in the country. CJC-1295 no DAC is supplied only for in-vitro research to adults 18 and over, not for human or veterinary use.

1
Frequently bought together
Ipamorelin 10mg$109.99
For in-vitro laboratory research only. Not for human or veterinary use. Purchasers must be 18 or over.
CompoundCJC-1295 no DAC
Amount10 mg
FormLyophilised powder
CategoryGrowth hormone research
Storage-20 °C, protect from light
TestingHPLC purity and mass spectrometry identity, every batch
Certificate of analysisAvailable for every lot, matched to the lot number on the label
Peptide calculator

CJC-1295 no DAC 10mg vial

Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.

Vial content
10 mg
mg per mL5.00
mcg per mL5,000

Buy CJC-1295 no DAC Australia: Mod GRF 1-29 in 2mg to 10mg Vials

Macropus Peptides supplies the short-acting form of this releasing hormone analogue in 2mg, 5mg and 10mg vials. The 10mg vial carries a set price and goes straight into the cart; the 2mg and 5mg sizes share its specification and are priced by quote. It is the most requested GHRH analogue in our range and the backbone of our most popular blend.

What is CJC-1295 no DAC

Often sold under the name Mod GRF 1-29, short for modified growth hormone releasing factor 1-29, this peptide keeps the active opening section of human GHRH and changes four amino acids in it. A D-alanine at position 2 stops the enzyme DPP-4 from snipping off the front of the chain. Glutamine at position 8 avoids a slow chemical change called deamidation, alanine at 15 helps the chain hold its active shape, and leucine at 27 replaces a methionine that oxidises easily. There is no linker attached, which is the difference from the DAC version and the reason it acts for a short time.

How short-acting CJC-1295 works in research

Like natural GHRH, the analogue binds the GHRH receptor on growth hormone producing cells of the anterior pituitary. The receptor raises cyclic AMP, which prompts the cell to release stored growth hormone and make more. Because the free peptide is cleared within a short window, each addition gives one pulse followed by a return to baseline. That on and off pattern mirrors the way the hypothalamus actually signals, so the peptide is used to study pulsatile release, how pituitary cells recover between signals, and how the GHRH input combines with a second input through the ghrelin receptor.

Short-acting CJC-1295 research: what the studies show

The hormone it copies was isolated in 1982 from pancreatic tumours by two separate groups, published in Science and in Nature, work that also showed the first 29 amino acids carried the activity. That modified chain, with four stabilising swaps, is the scaffold on which the albumin-linked analogue of a 2005 Endocrinology report was built. A year later, healthy-adult data (Journal of Clinical Endocrinology and Metabolism, 2006) put a number on how much longer the linked version persisted, which remains the plainest published contrast between the two forms. Published work on the free peptide is summarised in our CJC-1295 no DAC research studies library.

CJC-1295 vial specifications and storage

SpecificationDetail
CompoundCJC-1295 no DAC
Amount10 mg
FormLyophilised powder
CategoryGrowth hormone research
Storage-20 °C, protect from light

Every vial is filled with dry lyophilised peptide and capped with a stopper and crimped aluminium seal. Its label records the peptide, milligram amount, production lot and the storage temperature. Ask for the certificate of analysis by quoting the lot, and the report for that exact batch comes back to you. Keep unmixed stock frozen at -20 °C, in the dark, until a study begins.

CJC-1295 no DAC price in Australia

StrengthPricePrice per mg
CJC-1295 no DAC 2mgPrice to confirm-
CJC-1295 no DAC 5mgPrice to confirm-
CJC-1295 no DAC 10mg$109.99$11.00 per mg

Our 10mg size is priced outright and, being the biggest fill, carries the keenest cost per milligram available on this analogue. Quotes for the 2mg and 5mg sizes are returned on request and are expected to sit higher per milligram, which makes sense for pilot work and less so for a full study.

CJC-1295 no DAC 10mg: where to buy in Australia

This is the size most laboratories order. Ten milligrams carries a pulsatile study through its full run on one lot. Diluted in 2 mL it becomes a 5 mg per mL solution; spread across 5 mL it drops to 2 mg per mL.

CJC-1295 no DAC 5mg for mid-sized protocols

The 5mg vial fits a shorter series or a single arm of a larger design. Adding 2.5 mL brings it to 2 mg per mL, matching what the 10mg vial reaches in 5 mL.

CJC-1295 no DAC 2mg for method checks

The smallest size lets a laboratory confirm handling and assay response before ordering more. Mixed with 1 mL it reaches 2 mg per mL.

CJC 1295 DAC or no DAC: which form to buy

Structurally the two are twins except for the drug affinity complex on the DAC version, which ties the peptide to albumin and keeps it active for days. The free form, sold here, lasts minutes, so the pituitary sees a pulse rather than a steady push. Researchers modelling natural rhythmic release, or pairing the GHRH signal with a short-acting ghrelin agonist, choose this form; those studying continuous stimulation choose CJC-1295 with DAC. Sermorelin, the unmodified 1-29 sequence, is a useful comparator for either.

Buy CJC 1295 no DAC: why order from us

  • The 10mg vial priced for immediate checkout, smaller sizes quoted
  • A single specification from 2mg up to 10mg
  • Lot number on each label, with its certificate of analysis on request
  • The CJC-1295 and Ipamorelin blend and a CJC-1295 starter kit stocked alongside
  • Dispatch from Australian stock to Australian research addresses

Buy CJC 1295 online: how to order

  • Select the priced 10mg vial, or message us for 2mg and 5mg figures
  • If your design uses a ghrelin receptor agonist, add Ipamorelin as a separate vial
  • Pick up a bottle of reconstitution water in the same parcel
  • Tick the age and research-purpose declarations when paying
  • Record the lot number on arrival for certificate requests

CJC-1295 calculator: bac water for 2mg, 5mg and 10mg

Stock strength equals vial milligrams over millilitres of diluent. Two milligrams in 1 mL is 2 mg per mL. Five milligrams in 2 mL is 2.5 mg per mL. Ten milligrams in 2 mL is 5 mg per mL, and in 4 mL it is 2.5 mg per mL. Diluent for any of these sums is our bacteriostatic water.

Is CJC-1295 no DAC available in Australia

It is, as a research-only chemical. Nothing containing it is registered on the ARTG, which rules out sale for human or animal use; our supply is for in-vitro work. The TGA's Poisons Standard lists growth hormone releasing factors, and entries change over time, so make sure you know how it applies to your laboratory.

CJC-1295 no DAC for sale Australia wide

From our Australian dispatch point, parcels travel to research sites across the country. Browse the growth hormone peptide range for Ipamorelin, Tesamorelin and the ghrelin receptor agonists GHRP-2 and GHRP-6.

References

  1. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science. 1982.
  2. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature. 1982.
  3. hGRF1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 2005.
  4. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. Journal of Clinical Endocrinology and Metabolism. 2006.

Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.

Questions about CJC-1295 no DAC

Chat on WhatsApp
CJC-1295 no DAC 10mg$109.99